Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.7K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Epigenetic Regulation01:37

Epigenetic Regulation

3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

5.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

6.9K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular insights and therapeutic implications for the tumor suppressor role of LKB1 in non-small cell lung cancer.

Cancer letters·2026
Same author

Discovery of New OTUB1 Covalent Ligands via Structure-Activity Relationship Studies for Targeted Protein Stabilization.

Journal of medicinal chemistry·2026
Same author

Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications.

Signal transduction and targeted therapy·2026
Same author

Molecular insights for the tumor suppressor role of SPOP in prostate cancer.

Biochimica et biophysica acta. Reviews on cancer·2026
Same author

Protein neddylation in lung tumorigenesis: Target validation and targeted therapy.

Fundamental research·2026
Same author

CD47 destabilization via manipulating the SPOP-USP2 axis augments macrophage phagocytosis and cancer immunotherapy.

Journal for immunotherapy of cancer·2026
Same journal

The importance of HPV testing in oropharyngeal cancer in two US populations.

Neoplasia (New York, N.Y.)·2026
Same journal

Multi-omics characterization of radiation-induced cerebellar remodeling and tumorigenic transcriptional programs.

Neoplasia (New York, N.Y.)·2026
Same journal

Deep learning of pretreatment ascites cytopathology for platinum-resistance risk stratification in advanced epithelial ovarian cancer.

Neoplasia (New York, N.Y.)·2026
Same journal

The benefit of deep genomic testing for asymptomatic high-risk individuals undergoing surveillance for pancreatic adenocarcinoma: European registry for hereditary pancreatic diseases (EUROPAC-PLUS).

Neoplasia (New York, N.Y.)·2026
Same journal

Heterogeneous SPP1-expressing esophageal cancer cells license immunotherapy resistance by organizing an immunosuppressive niche.

Neoplasia (New York, N.Y.)·2026
Same journal

Fusion gene heterogeneity and kinase enrichment in high-grade serous carcinomas.

Neoplasia (New York, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: Jul 28, 2025

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells
08:11

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Published on: August 7, 2021

4.2K

PRMT1 methylates METTL14 to modulate its oncogenic function.

Jingchao Wang1, Zhen Wang1, Hiroyuki Inuzuka1

  • 1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.

Neoplasia (New York, N.Y.)
|June 3, 2023
PubMed
Summary
This summary is machine-generated.

Protein arginine methyltransferase 1 (PRMT1) methylates METTL14, a key component of the m6A writer complex. This arginine methylation regulates m6A modification and promotes cell proliferation, suggesting a role in tumorigenesis.

Keywords:
Arginine methylationMETTL14N6-methyladenosine (m6A)PRMT1

More Related Videos

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy
07:02

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy

Published on: December 16, 2021

1.5K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

182

Related Experiment Videos

Last Updated: Jul 28, 2025

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells
08:11

Quantitative Methods to Study Protein Arginine Methyltransferase 1-9 Activity in Cells

Published on: August 7, 2021

4.2K
Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy
07:02

Exploring the Arginine Methylome by Nuclear Magnetic Resonance Spectroscopy

Published on: December 16, 2021

1.5K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

182

Area of Science:

  • Epigenetics
  • RNA biology
  • Cancer research

Background:

  • N6-methyladenosine (m6A) is a crucial mRNA modification regulating stability and splicing.
  • The METTL3-METTL14-WTAP complex catalyzes m6A, but its upstream regulation is poorly understood.
  • Post-translational modifications, particularly arginine methylation, are implicated in regulating protein function.

Purpose of the Study:

  • To investigate the role of protein arginine methyltransferases (PRMTs) in regulating the m6A writer complex.
  • To identify upstream regulators of METTL14 function at the post-translational level.
  • To elucidate the impact of METTL14 arginine methylation on m6A modification and cellular processes.

Main Methods:

  • Investigated the interaction between PRMT1 and METTL14.
  • Identified specific arginine residues on METTL14 methylated by PRMT1.
  • Assessed the functional consequences of METTL14 arginine methylation on m6A modification and cell proliferation.
  • Utilized the PRMT1 inhibitor MS023 to study the effects of methylation inhibition.

Main Results:

  • PRMT1 directly methylates arginine residues in the C-terminus of METTL14.
  • The reader protein SPF30 recognizes PRMT1-mediated arginine methylation on METTL14.
  • PRMT1-dependent arginine methylation of METTL14 is essential for m6A modification.
  • Arginine methylation of METTL14 promotes cell proliferation, an effect inhibited by MS023.

Conclusions:

  • PRMT1-mediated arginine methylation of METTL14 is a novel regulatory mechanism for m6A modification.
  • This modification plays a significant role in promoting cell proliferation and tumorigenesis.
  • Targeting PRMT1 could be a potential therapeutic strategy for cancers associated with aberrant m6A modification.